Inra spinout Nextbiotix has attracted capital from the institute itself as well as Biocodex and other institutional investors.

CNA Financial, NN Group and an unnamed insurance provider have supplied $75m for MTech's InsureTech fund, which has targeted a $150m close.

Andera Partners has led a $55m funding round for Dynacure, co-founded by Satt Conectus to commercialise research from the Institute of Genetic and Molecular and Cellular Biology.

The Leap Fund will back early-stage, risky research that would not be able to secure funding through other channels.

Gunilla Lundmark has been hired as managing director of Uppsala University Holding, succeeding founding chief executive Lars Jonsson.

Unternehmertum Venture Capital Partners has agreed to sell its shares in AMW as part of an acquisition led by Hybio Pharmaceutical and Yunfeng Capital.

Microbiological labelling system developer C4 Diagnostics, which is partly based on Aix-Marseille Université research, has been backed by investors including Bpifrance.

Colposcope developer Dysis has closed a series B round featuring existing investor Lundbeckfonden Ventures that will fund growth and R&D.